Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1827
http://purl.obolibrary.org/obo/NCIT_C1827
|
|---|---|
| Preferred Name | Triplatin Tetranitrate |
| Definitions |
A cationic tri-nuclear platinum complex related to cisplatin. BBR 3464 binds to and forms DNA crosslinks and platinum-DNA adducts, preventing DNA replication and tumor cell division.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A cationic tri-nuclear platinum complex related to cisplatin. BBR 3464 binds to and forms DNA crosslinks and platinum-DNA adducts, preventing DNA replication and tumor cell division. |
|---|---|
| prefLabel | Triplatin Tetranitrate
|
| label | Triplatin Tetranitrate
|
| PDQ_Closed_Trial_Search_ID | 38246
|
| code | C1827
|
| prefixIRI | NCIT:C1827
|
| in_subset | |
| Preferred_Name | Triplatin Tetranitrate
|
| FDA_UNII_Code | HAJ1000ARC
|
| Contributing_Source | FDA
|
| Maps_To | Triplatin Tetranitrate
|
| CAS_Registry | 172903-00-3
|
| NCI_Drug_Dictionary_ID | 38246
|
| Legacy Concept Name | BBR_3464
|
| type | |
| ALT_DEFINITION | A substance that is being studied as an anticancer drug. It belongs to the family of platinum-based drugs.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 38246
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
| UMLS_CUI | C0756613
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |